Order and disorder: The role of extracellular matrix in epithelial cancer

Cancer Investigation

Volumn 20, Issue 1, 2002, Pages 139-153

  Radisky, Derek ^a   Muschler, John ^a   Bissell, Mina J ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; COLLAGEN; ENTACTIN; EXTRACELLULAR MATRIX RECEPTOR; FIBRONECTIN; INTEGRIN; LAMININ; PERLECAN; PROTEOGLYCAN; TENASCIN; UNCLASSIFIED DRUG;

BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL; CELL ADHESION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL GROWTH; CELL INTERACTION; CONFERENCE PAPER; EXTRACELLULAR MATRIX; HUMAN; MAMMARY GLAND; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANTIGENS, NEOPLASM; EXTRACELLULAR MATRIX; NEOPLASMS, GLANDULAR AND EPITHELIAL; SIGNAL TRANSDUCTION;

EID: 0036178475     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120000374     Document Type: Conference Paper

References (146)

1. How does extracellular matrix direct gene expression?
2. Integrin signaling and cell growth control
3. Integrin and ECM functions: Roles in vertebrate development
4. Insights into extracellular matrix functions from mutant mouse models
5. Stuck on the ECM
6. Extracellular matrix remodeling and cellular differentiation
7. The Tenascin Family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling
8. The structural and mechanical complexity of cell-growth control
9. Cell adhesion: The molecular basis of tissue architecture and morphogenesis
10. Tumors are unique organs defined by abnormal signaling and context
11. Structure and biological activity of the extracellular matrix
12. The role of laminins in basement membrane function
13. Roles for laminin in embryogenesis: Exencephaly, syndactyly, and placentopathy in mice lacking the laminin α5 chain
14. Absence of basement membranes after targeting the LAMC1 gene results in embryonic lethality due to failure of endoderm differentiation
15. Form and function: The Laminin Family of heterotrimers
16. Laminin α1-chain shows a restricted distribution in epithelial basement membranes of fetal and adult human tissues
17. Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice
18. Laminin mediates tissue-specific gene expression in mammary epithelia
19. The human mammary gland basement membrane is integral to the polarity of luminal epithelial cells
20. Self-assembly of laminin isoforms
21. Laminin polymerization induces a receptor-cytoskeleton network
22. Aberrant differentiation of neuromuscular junctions in mice lacking s-laminin/laminin β2
23. Roles of laminin in embryogenesis: Exencephaly syndactyly, and placentopathy in mice lacking the laminin α5 chain
24. Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells
25. Laminin-binding integrins in tumor progression and metastasis
26. New functions for non-collagenous domains of human collagen type IV
27. Assembly of type IV collagen
28. X-linked alport syndrome: Natural history in 195 families and genotype-phenotype correlations in males
29. Nidogen-2: A new basement membrane protein with diverse binding properties
30. Structural and genetic analysis of laminin-nidogen interaction
31. Nidogen-1 regulates laminin-1-dependent mammary-specific gene expression
32. Functions of cell surface heparan sulfate proteoglycans
33. Perlecan maintains the integrity of cartilage and some basement membranes
34. An anti-oncogenic role for decorin
35. The cell-surface heparan sulfate proteoglycan glypican-I regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer
36. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the golgi apparatus and catalyzes the synthesis of heparan sulfate
37. New perspectives on the molecular basis of hereditary bone tumors
38. Bidirectional signaling between the cytoskeleton and integrins
39. Modulation of cell-extracellular matrix interactions
40. The structural and mechanical complexity of cell-growth control
41. Fibronectin and integrins in cell adhesion signaling, and morphogenesis
42. Ligand binding to integrins
43. Implications of atomic-resolution structures for cell adhesion
44. RGD and other recognition sequences for integrins
45. Extracellular matrix and integrin signalling: The shape of things to come
46. Complexity and specificity of integrin signaling
47. Integrins and actin filaments: Reciprocal regulation of cell adhesion and signaling
48. Focal adhesions - The cytoskeletal connection
49. Focal adhesions: A nexus for intracellular signaling and cytoskeletal dynamics
50. Signaling from Ras to Rac and beyond: Not just a matter of GEFs
51. Rho GTPases: Signaling migration and invasion
52. Epithelial cell shape: Cadherins and small GTPases
53. Integrin affinity modulation
54. Regulation of The extracellular ligand binding activity of integrins
55. Signal transduction and signal modulation by cell adhesion receptors: The role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins
56. Rho GTPases and the actin cytoskeleton
57. Signaling networks linking integrins and rho family GTPases
58. Focal adhesion kinase mediates the integrin signaling requirement for growth factor activation of MAP kinase
59. Focal adhesion kinase in integrin-mediated signaling
60. Activated ERK/MAP kinase is targeted to newly-forming cell-matrix adhesions by integrin engagement and v-Src
61. 2-terminal kinase and progression through the g1 phase of the cell cycle
62. 2-terminal kinase
63. Integrin signaling
64. Integrin signaling and cell growth control
65. Regulation of STAT3 by direct binding to the Rac1 GTPase
66. Syndecan-regulated receptor signaling
67. Syndecans: Multifunctional cell-surface co-receptors
68. The syndecans, tuners of transmembrane signaling
69. Integrin modulation by lateral association
70. Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice
71. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
72. Distribution of dystroglycan in normal adult mouse tissues
73. Dystroglycan versatility
74. Dystroglycan inside and out
75. Analysis of heparin αdystroglycan, and sulfatide binding to the G domain of the laminin α1 chain by site-directed mutagenesis
76. The relationship between perlecan and dystroglycan and its implication in the neuromuscular junction
77. Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, αdystroglycan and several extracellular matrix proteins
78. Dystroglycan is essential for early embryonic development: Disruption of Reichert's membrane in Dag1-null mice
79. A role of dystroglycan in basement membrane assembly
80. Cadherins and their connections: Adhesion junctions have broader functions
81. E-cadherin null mutant embryos fail to form a trophectoderm epithelium
82. A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development
83. 2+ dependence and mutational analysis reveal molecular details of E-cadherin homoassociation
84. Mechanism of cell-cell adhesion complex assembly
85. E-cadherin-mediated cell-cell atachment activates Cdc42
86. Role of IQGAP1, a target of the small GTPases Cdc41 and Rac1, in regulation of E-cadherin-mediated cell-cell adhesion
87. Cell-substrate interactions and signaling through ILK
88. The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton
89. Cadherins and tissue formation: Integrating adhesion and signaling
90. The integration of cell adhesion with gene expression: The role of β-catenin
91. WNT signaling in oncogenesis and embryogenesis - A look outside the nucleus
92. The morphogenetic role of cadherin cell adhesion molecules in human cancer: A thematic review
93. Insights from model systems: The tumor-suppressor function of E-cadherin
94. The role of the cell-adhesion molecule E-cadherin as a tumor suppressor gene
95. A causal role for E-cadherin in the transition from adenoma to carcinoma
96. E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium
97. Tissue structure, nuclear organization, and gene expression in normal and malignant breast
98. Isolation and characterization of type IV procollagen laminin, and heparan sulfate proteoglycan from the EHS sarcoma
99. Interaction of mouse mammary epithelial cells with collagen substrata: Regulation of casein gene expression and secretion
100. Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells
101. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane
102. Cytodifferentiation of mouse mammary epithelial cells cultured on a reconstituted basement membrane reveals striking similarities to development in vivo
103. Control of mammary epithelial differentiation: Basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity
104. Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction
105. Extracellular matrix regulates whey acidic protein gene expression of TGF-α in mouse mammary epithelial cells: Studies in culture and in transgenic mice
106. Genetic instabilities in human cancers
107. Molecular genetics of breast cancer progression
108. Estimation of mutation frequencies in normal mammalian cells and the development of cancer
109. Genetic instability and Darwinian selection in tumors
110. The war on cancer
111. Cancer: Looking outside the genome
112. The hallmarks of cancer
113. Signalling networks that cause cancer
114. Extracellular matrix remodelling and cellular differentiation
115. ECM and cell surface proteolysis: Regulating cellular ecology
116. Matrix metalloproteinases: Effectors of development and normal physiology
117. ECM signalling: Orchestrating cell behavior and misbehavior
118. Matrix metalloproteinases: Multifunctional contributors to tumor progression
119. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix
120. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle
121. Targeted expression of stromelysin-1 in mammary gland provides evidence for proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression
122. Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development
123. Mammary gland formation in transgenic mice overexpressing stromelysin-1
124. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis
125. Rescue of mammary epithelial cell apotosis and entactin degradation by a tissue inhibitor of metalloproteinases transgene
126. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter
127. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties
128. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells
129. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis
130. Stromelysin-3 expression promotes tumor take in nude mice
131. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy
132. Extrinsic regulators of epithelial tumor progression: Metalloproteinases
133. Shape-dependent control of cell growth differentiation and apoptosis: Switching between attractors in cell regulatory networks
134. Structural cues from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype
135. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells
136. A new diploid nontumorgenic human breast epithelial cell line isolated and propagated in chemically defined medium
137. Altered gene expression of C-Myc epidermal growth factor receptor, transforming growth factor-α, and C-Erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements
138. Gradual selection of a cellular clone presenting a mutation at codon 179 of the p53 gene during establishment of the immortalized human breast epithelial cell line HMT-3522
139. In vitro karyotype evolution in a cell line established from nonmalignant human mammary epithlium
140. Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal
141. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies
142. Integrins and cancer
143. Role of integrins in cancer: Survey of expression patterns
144. 1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology
145. 1 integrins, and an E3 laminin receptor to signal morphogenesis and β-casein expression in mammary epithelial cells